In the U.S., atrial fibrillation (AF), a heart condition that causes an irregular heartbeat in the upper chambers of the ...

In the U.S., atrial fibrillation (AF), a heart condition that causes an irregular heartbeat in the upper chambers of the heart, affects up to one in three people in their lifetime. Significant ...

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrhythmias, today ...

A New Pacemaker Algorithm for the Treatment of Atrial Fibrillation: Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT) Electrophysiologic Characteristics of the Spontaneous Onset and ...

A combination of Imbruvica and venetoclax showed significantly prolonged progression-free survival in patients with untreated ...

Six antiarrhythmic drugs are often used to treat atrial fibrillation: propafenone, flecainide, sotalol (Betapace), dofetilide (Tikosyn), amiodarone, and dronedarone (Multaq). For anybody taking these ...

In patients with atrial fibrillation, a resting heart rate of 80 bpm or higher is associated with increased risk for mortality.

The first-in-human trial is taking place at Na Homolce hospital in Prague, Czech Republic, and will treat up to 50 patients.

The global Ablation Technology Market is projected to reach USD 13.61 Billion by 2031 from USD 5.78 Billion in 2024, at a CAGR of 9.34% from 2024 to 2031.Luton, Bedfordshire, United Kingdom, Dec. 18, ...

While most physicians may also screen newly diagnosed heart failure patients for atrial fibrillation, Dr. May said these ...

Athletes who undergo ablation to treat their irregular heartbeat caused by atrial fibrillation (AF) experience greater ...